Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Nov 12, 7:36 AMMangoceuticals files SEC Form 1-A for up to $10 million in tokenized Series D preferred stock
Index
-
Market Cap
3.55M
Enterprise Value
3.64M
Income
-15.99M
Sales
0.32M
Book/sh
0.70
Cash/sh
0.01
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
3
IPO
Mar 21, 2023
P/E
-
Forward P/E
-
PEG
-
P/S
11.10
P/B
0.23
P/C
15.44
P/FCF
-
EV/EBITDA
-
EV/Sales
11.38
Quick Ratio
0.18
Current Ratio
0.18
Debt/Eq
0.03
LT Debt/Eq
0.02
Option/Short
No / Yes
EPS (ttm)
-1.17
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
-7.77% -244.95%
Sales past 3/5Y
270.88% -
EPS Y/Y TTM
63.25%
Sales Y/Y TTM
-38.91%
EPS Q/Q
82.71%
Sales Q/Q
-59.10%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
21.25%
Insider Trans
0.00%
Inst Own
8.94%
Inst Trans
16.41%
ROA
-85.72%
ROE
-94.42%
ROIC
-118.21%
Gross Margin
-384.90%
Oper. Margin
-4272.95%
Profit Margin
-5071.14%
SMA20
-27.84%
SMA50
-52.46%
SMA200
-58.99%
Trades
Shs Outstand
18.02M
Shs Float
17.50M
52W High
1.49 -89.26%
52W Low
0.15 7.02%
Volatility
15.00% 14.39%
ATR (14)
0.03
RSI (14)
26.61
Beta
2.24
Rel Volume
0.42
Avg Volume
1.02M
Volume
383,446
Perf Week
-18.78%
Perf Month
-44.81%
Perf Quarter
-65.96%
Perf Half Y
-60.49%
Perf YTD
-78.38%
Perf Year
-89.19%
Perf 3Y
-97.52%
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
0.16
Price
0.16
Change %
3.23%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHNSTON EUGENE MCFODec 15 '25Sale1.173,3333,884120,000Dec 17 05:00 PM
JOHNSTON EUGENE MCFODec 09 '25Sale1.205,0005,975123,333Dec 11 04:05 PM
JOHNSTON EUGENE MCFODec 05 '25Sale1.1310,00011,280128,333Dec 09 05:16 PM
JOHNSTON EUGENE MOfficerDec 03 '25Proposed Sale1.16128,333148,866Dec 03 10:03 AM
Hamilton Alex P.DirectorNov 19 '25Sale1.22125,000152,8753,334Nov 26 04:30 PM
Hamilton Alex P.DirectorNov 19 '25Proposed Sale1.24125,000155,125Nov 19 11:46 AM
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.
Co-FounderMr. Jacob D. Cohen
Chief Financial OfficerMr. Eugene M. Johnston